VANBRUGH GROUP PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: G83021 | LONDON, SE10 9GB
Showing results 101-150 of 613
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Montelukast | 363 | 18.9K | £948 | -47.0% ▼ |
| Felodipine | 361 | 17.1K | £2.7K | -39.2% ▼ |
| Enalapril maleate | 360 | 14.3K | £499 | +100.4% ▲ |
| Mirabegron | 349 | 12.6K | £11.6K | -13.1% ▼ |
| 346 | 355 | £2.1K | +46.5% ▲ | |
| Ferrous fumarate | 337 | 20.3K | £661 | -53.5% ▼ |
| Insulin glargine | 333 | 1,641 | £14.4K | +17.3% ▲ |
| Paroxetine hydrochloride | 330 | 10.5K | £507 | +76.8% ▲ |
| Escitalopram | 330 | 13.3K | £766 | +16.0% ▲ |
| Clonazepam | 330 | 10.5K | £2.0K | +111.8% ▲ |
| Clarithromycin | 329 | 5,866 | £1.4K | +34.1% ▲ |
| Bendroflumethiazide | 326 | 15.7K | £260 | -57.9% ▼ |
| Spironolactone | 325 | 8,998 | £922 | -39.7% ▼ |
| Irbesartan | 322 | 12.6K | £509 | +32.2% ▲ |
| Alginic acid compound preparations | 312 | 189.4K | £2.4K | -46.7% ▼ |
| Nefopam hydrochloride | 309 | 25.2K | £1.2K | +173.2% ▲ |
| Diltiazem hydrochloride | 307 | 14.9K | £2.9K | +0.0% vs avg |
| Estriol | 304 | 4,136 | £6.2K | +42.9% ▲ |
| Ibuprofen | 304 | 35.8K | £820 | -40.2% ▼ |
| Sodium valproate | 302 | 68.1K | £6.0K | -5.1% ▼ |
| Latanoprost | 302 | 11.0K | £3.2K | -37.8% ▼ |
| Perindopril erbumine | 300 | 12.0K | £902 | -43.5% ▼ |
| Mometasone furoate | 298 | 349 | £2.7K | -25.8% ▼ |
| Warfarin sodium | 297 | 17.1K | £1.2K | -37.0% ▼ |
| Pravastatin sodium | 297 | 9,471 | £463 | -8.5% ▼ |
| Quinine sulfate | 293 | 8,292 | £1.3K | +1.2% vs avg |
| Carbamazepine | 288 | 20.8K | £1.5K | -3.0% ▼ |
| Dihydrocodeine tartrate | 286 | 23.6K | £1.5K | +46.4% ▲ |
| Cetirizine hydrochloride | 284 | 48.3K | £3.1K | -43.2% ▼ |
| Fluticasone furoate | 275 | 320 | £2.4K | +42.0% ▲ |
| Typhoid | 274 | 274 | £2.8K | +204.3% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 268 | 19.2K | £1.3K | +18.6% ▲ |
| Diphtheria | 267 | 267 | £1.9K | +300.1% ▲ |
| Isosorbide mononitrate | 264 | 10.2K | £1.2K | -60.1% ▼ |
| Hyoscine butylbromide | 257 | 17.9K | £1.2K | +10.3% ▲ |
| Loperamide hydrochloride | 257 | 19.0K | £477 | +10.3% ▲ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 250 | 311 | £4.4K | +120.4% ▲ |
| Carbocisteine | 248 | 30.5K | £1.1K | -53.5% ▼ |
| Atenolol | 247 | 13.7K | £304 | -59.0% ▼ |
| Hepatitis A | 247 | 247 | £4.8K | +225.3% ▲ |
| Mesalazine (Systemic) | 246 | 45.5K | £22.1K | +2.7% ▲ |
| Estradiol | 244 | 6,106 | £3.1K | -9.6% ▼ |
| Aripiprazole | 243 | 5,215 | £1.4K | -4.5% ▼ |
| Mebeverine hydrochloride | 239 | 15.6K | £571 | -23.0% ▼ |
| Methenamine hippurate | 239 | 14.6K | £3.7K | +162.7% ▲ |
| Azathioprine | 237 | 12.1K | £292 | +118.7% ▲ |
| Fluticasone propionate (Inhalation) | 235 | 370 | £8.6K | -39.3% ▼ |
| Methotrexate | 233 | 6,410 | £383 | -28.4% ▼ |
| Calcipotriol | 233 | 20.6K | £10.7K | +36.9% ▲ |
| Thiamine hydrochloride | 232 | 9,599 | £262 | -56.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.